SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Zim Integrated Shipping Services is trending as Hapag-Lloyd confirms a $35 per share acquisition, sparking community debate over the offer's valuation compared to ZIM's book value and potential for dividends before the deal's 2026 close, all while intensifying discussion around a significant short squeeze.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium (HNT) is trending as the community discusses its AT&T partnership for expanded Wi-Fi connectivity and the dismissal of its SEC lawsuit, with many anticipating a rally driven by these developments, institutional interest from a Grayscale trust, and tokenomics changes that consolidate rewards into HNT, despite ongoing skepticism from some regarding past performance.

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Celldex Therapeutics Inc.

Celldex Therapeutics is trending following strong clinical data for its lead drug barzolvolimab in chronic urticaria, with the community anticipating it as a potential best-in-class treatment or buyout target despite ongoing discussions about its safety profile and long development timeline.

MasTec, Inc. engages in the provision of infrastructure construction services. It operates through the following segments: Communications, Oil and Gas, Clean Energy and Infrastructure, and Other. The Communications segment performs engineering, construction, maintenance, and customer fulfillment activities related to communications infrastructure, primarily for wireless and wireline/fiber communications, and install-to-the-home customers. The Oil and Gas segment offers services on oil and natural gas pipelines and processing facilities for the energy and utilities industries. The Clean Energy and Infrastructure segment serves energy, utility and other end-markets through the installation and construction of power generation facilities, including from clean energy and renewable sources such as wind, solar and biomass, as well as various types of heavy civil and industrial infrastructure. The Other segment consists of equity investors, other small business units that perform construction, and other services for a variety of international end-markets. The company was founded by Jorge Mas Canosa on July 26, 1968, and is headquartered in Coral Gables, FL.

Mastec Inc.

MasTec is capturing market attention with strong financial results and multiple analyst upgrades, positioning it as a key beneficiary of accelerating public infrastructure spending and the surging demand for AI-driven data center and power grid construction, prompting community discussions on its growth trajectory and premium valuation.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending after positive Phase 3 data from Roche for a similar breast cancer drug ignited optimism for OLMA's lead asset, palazestrant. This has spurred upgraded analyst price targets and buyout speculation, though some investors are wary of insider selling and recent share offerings.

Green Plains, Inc. engages in the production of fuel-grade ethanol and corn oil, the provision of grain handling, and storage commodity marketing and distribution services. It operates through the following segments: Ethanol Production and Agribusiness and Energy Services. The Ethanol Production segment produces ethanol, distillers' grain, and corn oil at ethanol plants in Indiana, Iowa, Minnesota, Nebraska, Tennessee, and Texas. The Agribusiness and Energy Services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, renewable corn oil, natural gas and other commodities. The company was founded in June 2004 and is headquartered in Omaha, NE.

Green Plains Inc

Green Plains is trending due to anticipation of significant value from 45Z clean fuel tax credits tied to its carbon capture initiatives and the potential for increased ethanol demand with broader E15 rollout. The community is actively discussing how these policy-driven catalysts and recent strategic moves could re-rate the stock in the evolving biofuels sector.

Codatta

Codatta ($XNY) is trending for its notable resilience and strong price action amid broader market pullbacks, leading the community to actively accumulate and anticipate significant upside. Discussion highlights its AI/data utility and a history of volatile, explosive price movements as key drivers.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

The cryptocurrency $DOG is trending amidst strong community excitement over its reported rollout of support on Coinbase, with investors viewing it as the premier Bitcoin-native memecoin poised for significant growth and challenging established rivals.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kimberly-Clark's acquisition bid for Kenvue, valuing shares at $21.01, is driving significant arbitrage interest, even as community sentiment remains divided over ongoing Tylenol litigation and its potential impact on the deal and the acquiring company's outlook.

CEMEX SAB de CV operates as a global construction materials company. It offers cement, ready-mixconcrete, aggregates, and urbanization solutions. The firm operates through the following geographical segments: Mexico, United States, Europe, Middle East, Africa and Asia (EMEAA) and South, Central America and the Caribbean (SCA&C). The company was founded by Lorenzo Zambrano Gutierrez in 1906 and is headquartered in San Pedro Garza Garcia, Mexico.

Cemex S.A.B. De C.V. - ADR

CEMEX, S.A.B. de C.V.

CEMEX is trending due to its strong Q4 earnings and a proposed quarterly dividend, fueling optimistic community discussion around its recent investment-grade status and potential for double-digit growth. This momentum is supported by robust institutional buying and accelerating demand for construction and infrastructure, particularly as Mexico emerges as a key manufacturing hub.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Research Issues Positive Forecast for Marsh Earnings

Marsh (NYSE:MRSH - Free Report) - Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Marsh in a report issued on Friday, February 13th. Zacks Research...

Plug Power Stockholders Approve Share Increase to 3B, Reject Charter Vote-Rule Change at Special Meeting

Plug Power (NASDAQ:PLUG) held its 2026 special meeting of stockholders virtually on February 12, 2026, after the meeting was originally convened on January 29 and subsequently adjourned to February 5...

Michael Lewis Named President, Marsh Risk Canada

Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today announced that Michael Lewis has been promoted to President, Marsh Risk...

See Which Of The Latest 13F Filers Holds MRSH

At Holdings Channel, we have reviewed the latest batch of the 37 most recent 13F filings for the 12/31/2025 reporting period, and noticed that Marsh & McLennan Companies Inc (Symbol: MRSH) was held...

Marsh Announces Pricing of $600 Million Senior Notes Offering

Marsh (NYSE: MRSH) (the Company) announced today that it has priced $600 million aggregate principal amount of its 4.950% Senior Notes due 2036 (the Notes). The Company intends to use the net...

Marsh (NYSE:MRSH) Shares Down 5.4% - What's Next?

Marsh (NYSE:MRSH) Shares Down 5.4% - Here's What Happened...

Marsh (NYSE:MRSH) Issues Earnings Results

Marsh (NYSE:MRSH - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $2.12 EPS for the quarter, topping analysts' consensus estimates of $1.97 by $0.15. The...

Morgan Stanley Forecasts Strong Price Appreciation for Marsh (NYSE:MRSH) Stock

Morgan Stanley raised their price objective on shares of Marsh from $190.00 to $195.00 and gave the company an "equal weight" rating in a research note on Friday...

Royal Bank Of Canada Reaffirms Sector Perform Rating for Marsh (NYSE:MRSH)

Royal Bank Of Canada reiterated a "sector perform" rating and set a $200.00 price target on shares of Marsh in a research report on Friday...

Wells Fargo & Company Raises Marsh (NYSE:MRSH) Price Target to $203.00

Wells Fargo & Company raised their price target on Marsh from $199.00 to $203.00 and gave the stock an "equal weight" rating in a research report on Friday...

Marsh & McLennan Cos., Inc. is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services. The Consulting segment offers health, wealth, and career solutions and products, and specialized management, strategic, economic, and brand consulting services. The company was founded by Henry W. Marsh and Donald R. McLennan in 1871 and is headquartered in New York, NY.

Marsh

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

MMC
Marsh & McLennan Cos., Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MMC News

MMCMarsh & McLennan Cos., Inc.